Pikarsky Eli

Medicine & Life Sciences

1. Neoplasms 100%
2. Hepatocellular Carcinoma 81%
3. Inflammation 51%
4. Carcinogenesis 43%
5. Growth 39%
6. Liver 37%
7. Mutation 36%
8. Ubiquitination 32%
9. Breast Neoplasms 30%
10. Genes 28%
11. Liver Neoplasms 26%
12. Colorectal Neoplasms 25%
13. Apoptosis 22%
14. Hepatocytes 21%
15. Tumor Microenvironment 20%
16. Lung Neoplasms 20%
17. Proteins 19%
18. Ubiquitin 18%
19. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 17%
20. Prostatic Neoplasms 17%
21. Methylation 17%
22. Phenotype 16%
23. Sorafenib 16%
24. MicroRNAs 16%
25. Therapeutics 15%
26. Ligands 15%
27. Immunotherapy 15%
28. Ligases 15%
29. Liver Regeneration 15%
30. Prostate 14%
31. Casein Kinase I 14%
32. Embryonal Carcinoma Stem Cells 14%
33. heparanase 14%
34. DNA Methylation 14%
35. Cell Proliferation 13%
36. Transcription Factors 13%
37. Cell Death 13%
38. Down-Regulation 13%
39. DNA Damage 13%
40. Homeostasis 13%
41. Up-Regulation 12%
42. Chromatin 12%
43. Carcinoma 12%
44. Heterografts 12%
45. Microbiota 11%
46. Transducers 11%
47. Immune System 11%
48. Epigenomics 11%
49. Tretinoin 11%
50. Histones 11%